DEI CAS, Livio
 Distribuzione geografica
Continente #
NA - Nord America 38.084
EU - Europa 27.096
AS - Asia 13.615
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 59
SA - Sud America 58
OC - Oceania 46
AN - Antartide 1
Totale 79.073
Nazione #
US - Stati Uniti d'America 37.945
UA - Ucraina 9.433
CN - Cina 8.836
IT - Italia 4.983
DE - Germania 3.453
HK - Hong Kong 1.934
FI - Finlandia 1.792
PL - Polonia 1.660
IE - Irlanda 1.362
GB - Regno Unito 1.272
SG - Singapore 1.261
FR - Francia 1.232
IN - India 1.180
RU - Federazione Russa 1.061
SE - Svezia 532
TR - Turchia 262
CA - Canada 123
MU - Mauritius 104
BE - Belgio 79
NL - Olanda 71
VN - Vietnam 63
EU - Europa 58
AU - Australia 40
BR - Brasile 32
CZ - Repubblica Ceca 30
IR - Iran 19
ES - Italia 18
CH - Svizzera 16
RO - Romania 16
AT - Austria 11
HU - Ungheria 11
ID - Indonesia 9
JP - Giappone 9
MX - Messico 9
GR - Grecia 8
SA - Arabia Saudita 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 6
AR - Argentina 6
LU - Lussemburgo 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
BG - Bulgaria 5
CL - Cile 5
PE - Perù 5
CO - Colombia 4
DK - Danimarca 4
IL - Israele 4
LV - Lettonia 4
PT - Portogallo 4
AZ - Azerbaigian 3
CY - Cipro 3
EG - Egitto 3
IQ - Iraq 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
VE - Venezuela 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
EC - Ecuador 2
EE - Estonia 2
JM - Giamaica 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
A1 - Anonimo 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NP - Nepal 1
SD - Sudan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 79.073
Città #
Jacksonville 6.792
Chandler 3.599
Fairfield 3.384
Woodbridge 3.014
Princeton 2.693
Nanjing 2.590
Ann Arbor 2.196
Houston 2.053
Ashburn 2.022
Wilmington 2.006
Hong Kong 1.925
Cambridge 1.794
Warsaw 1.642
Dublin 1.354
Seattle 1.120
Beijing 1.057
Moscow 1.024
Nanchang 973
New York 951
Singapore 726
Des Moines 665
Hebei 596
Shenyang 594
Milan 481
Changsha 442
Helsinki 429
Tianjin 422
Jiaxing 409
Dearborn 390
Kunming 307
San Diego 292
Jinan 266
Kocaeli 242
Verona 241
Rome 229
Hangzhou 199
Brescia 125
Lanzhou 114
Ningbo 114
Shanghai 114
Boardman 105
Lancaster 104
Zhengzhou 93
Changchun 83
San Francisco 82
Taizhou 81
Norwalk 78
Toronto 78
Brussels 66
Haikou 64
Guangzhou 62
Dong Ket 60
Florence 58
Palermo 50
Los Angeles 47
Fuzhou 45
Napoli 44
San Mateo 44
London 40
Pune 40
Catania 38
Taiyuan 38
Groningen 36
Augusta 34
Redwood City 33
Orange 31
Bologna 28
Monmouth Junction 26
Leawood 25
Naples 25
Torino 24
Auburn Hills 23
Bari 22
Dallas 22
Padova 22
Westminster 22
Caserta 21
Hefei 21
Washington 21
Canberra 20
Genova 20
São Paulo 19
Brno 18
Trieste 18
Genoa 17
Bergamo 16
Pescara 16
Ottawa 15
Hanover 14
Redmond 14
Turin 14
Ardabil 13
Nürnberg 12
Rende 12
Saint Petersburg 12
Trento 12
Kilburn 11
Mumbai 11
North York 11
Perugia 11
Totale 51.728
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 1.126
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 649
Reperti ecocardiografici in soggetti con alterazioni aspecifiche della ripolarizzazione ventricolare. 471
Inodilatatori: perché e quali. 363
Farmaci inotropi non digitalici. 314
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 284
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 266
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 251
Valutazione dell’indice di performance miocardica (MPI) del ventricolo destro con studio eco-doppler in pazienti affetti da insufficienza cardiaca. 247
Regressione dell’ipertrofia e della disfunzione diastolica del ventricolo sinistro dopo impianto di core valve in pazienti affetti da stenosi aortica severa 224
Can we improve the treatment of congestion in heart failure? 212
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 209
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 208
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 206
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 203
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 201
Old and new intravenous inotropic agents in the treatment of advanced heart failure 201
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 191
Prospective assessment of integrating the existing emergency medical system with automated external defibrillators fully operated by volunteers and laypersons for out-of-hospital cardiac arrest: the Brescia Early Defibrillation Study (BEDS) 188
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 186
Postdischarge assessment after a heart failure hospitalization: the next step forward. 185
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 183
Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. 183
Complicanze devastanti di una ateromasia complessa dell'aorta toracica. 170
Efficacy of a combination of natural lipid lowering agent in hypercholesterolemic patients. 170
Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. 165
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 164
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 154
Valvola aortica quadricuspide asintomatica : un caso clinico. 153
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 150
Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold 150
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 148
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 147
Fistola coronarica dal tronco comune al seno coronarico: il ruolo dell'ecocardiografia transesofagea. 146
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 145
Active-fixation coronary sinus pacing lead extraction: A hybrid approach 143
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 140
Fattori neuroumorali nello scompenso cardiaco: correlazione con l'eziologia, la gravità e la prognosi. 138
A Scombroid Poisoning Causing a Life-Threatening Acute Pulmonary Edema and Coronary Syndrome in a Young Healthy Patient 136
Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic? 134
Serum levels of different tumoral markers in patients with congestive heart failure. 132
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 127
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 126
Long-Term Prognostic Value of the Right Ventricular Myocardial Performance Index Compared to Other Indexes of Right Ventricular Function in Patients with Moderate Chronic Heart Failure 123
A focus on antiarrhythmic properties of ranolazine 119
Preoperative cardiac evaluation and perioperative cardiac therapy in patients undergoing open surgery for abdominal aortic aneurysms: effects on cardiovascular outcome 118
n-3 PUFAs and cardiovascular disease prevention. 116
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 115
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 115
Syncope and tumours in the neck: carotid sinus or glossopharyngeal syndrome? 114
Jugular pacing lead extraction with laser sheath: A case report 114
A Type A Aortic Dissection Mimicking an Acute Myocardial Infarction 114
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 114
L'Ibopamina nello scompenso cardiaco: studio clinico policentrico, effetti emodinamici a riposo e durante sforzo. 113
Long-Term Prognostic Value of CA 125 Serum Levels in Mild to Moderate Heart Failure Patients 113
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 112
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 112
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 111
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 110
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 110
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. 109
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. 109
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 108
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 108
Non-obstructive membranes of the left atrial appendage. 108
A rationale for the use of BETA-blockers as standard treatment for heart failure 107
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 107
Clinical significance of Beta-adrenergic receptor polymorphisms in the patients with chronic heart failure 107
Asse cuore-rene nell’iperteso cardiopatico. 106
Betabloccanti e arteriopatia degli arti inferiori. 106
Beta- adrenergic receptors polymorphisms and response to CRT 106
An echo-guided case report of rapid regression of unstable mobile thrombus aortic atheroma after aggressive statin and antiplatelet combination therapy 106
Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse 105
Ritmo circadiano della frequenza cardiaca in fibrillanti trattati con digossina e gitoformato. 105
Can we prevent or treat renal dysfunction in acute heart failure? 105
Laser sheath for tunneled dialysis catheters extraction 104
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 103
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. 103
Anemia and heart failure : a cause of progression or only a consequence? 102
Effetti emodinamici di Nitroprussiato e Ibopamina nello scompenso cardiaco grave. 101
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 101
Out-of-hospital cardiac arrest caused by transient left ventricular apical ballooning syndrome. 100
Absence of inferior vena cava as a rare cause of deep venous thrombosis complicated by liver and lung embolism. 100
QT prolongation: a case of arsenical pericardial and pleural effusion. 100
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 100
Rest and exercise effects of the acute and chronic administration of nisoldipine in patients with heart failure. 98
Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing 98
Percutaneous coronary angioplasty in a patient with anomalous single coronary artery arising from the right sinus of Valsalva 97
Abnormal hemodynamics and ventilatory response to exercise may identify chronic heart failure patients at high risk despite long term beta-blocker treatment. 97
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 97
Approccio ibrido nell'ablazione della Fibrillazione atriale persistente idiopatica: un'opzione terapeutica sicura ed efficace 97
Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse 97
Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy. 96
Different prognostic value of exercise electrocardiogram in men and women 96
Influence of the angiotensin-converting enzyme genotype on the response to the beta-blocker therapy and the prognosis of the patients with chronic heart failure. 96
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. 96
Erythropoietin: a new perspective in cardiovascular therapy 96
Clinical trials update from the World Congress of Cardiology 2006. 96
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. 96
Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. 95
Totale 15.696
Categoria #
all - tutte 360.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 360.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019.862 4.388 383 470 2.200 605 2.244 1.388 2.203 953 2.599 813 1.616
2020/202114.195 207 1.866 267 1.779 256 1.859 369 1.875 2.958 832 1.668 259
2021/20228.682 254 1.995 70 602 128 410 276 590 521 1.059 910 1.867
2022/20239.628 1.498 109 104 1.004 884 2.822 28 983 1.426 58 311 401
2023/20247.438 545 154 255 368 244 1.144 185 205 2.002 206 606 1.524
2024/2025274 274 0 0 0 0 0 0 0 0 0 0 0
Totale 79.835